Waves of influenza, like cold-causing coronaviruses, don’t come and go at random. They’re seasonal, recurring in patterns we can anticipate and plan ahead for. Will this be true of SARS-CoV-2?
Though the human coronavirus 229E isn’t nearly as hot a topic as SARS-CoV-2 these days, it is one of several coronaviruses that have been causing us colds for more than half a century. It also has lessons to teach us about the ability of coronaviruses …
The new administration’s Covid-19 plan signals a new era of competent and responsive leadership. Yet with the death toll surpassing 400,000, the plan needs to go much further.
Unless there’s a significant increase in production and distribution, billions will not receive the vaccine in 2021, most of which are located in low-income countries, which will result in hundreds of thousands, if not millions, of unnecessary deaths.
Under Secretary Azar and Administrator Verma’s stewardship, HHS and CMS have pursued an ambitious policy agenda on transparency, drug pricing, and medical device reimbursement, one the Biden Administration is unlikely to abandon.
We are rapidly learning how SARS-CoV-2 mutates to create variants with new characteristics. In a preprint published on January 11, scientists from the Weizmann Institute of Science describe an experiment in which they attempt to mimic what occurs natur…
Now that we’re ramping up our ability to surveil the virus and follow our leads, we must also pivot from a place of complacency to one of heightened vigilance.
While Covid-19 reinfections have been reported and confirmed previously, the case of one 45-year-old woman in Brazil is the first to involve the potentially dangerous mutation E484K.
Covid-19 policy measures brought unexpected side effects to the public health sphere. Transmission of other common viruses has hit record lows. Why has this happened, and what will the implications be when the pandemic comes to a close?